About Sinochem Pharmaceutical
Sinochem Pharmaceutical is a company based in Nanjing (China) founded in 1973. Sinochem Pharmaceutical has completed 1 acquisition, including Elix Polymers. Sinochem Pharmaceutical operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Nanjing, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Sinochem India Company Private Limited
- Date of Incorporation 22 Feb, 2008
- Jurisdiction Shakarpur, Delhi, India
-
Annual Revenue
$26.05 M (USD)-33.07as on Mar 31, 2022
-
Net Profit
$1.49 M (USD)-50.86as on Mar 31, 2022
-
EBITDA
$2.23 M (USD)-46.17as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sinochem Pharmaceutical
Detailed funding history for Sinochem Pharmaceutical
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sinochem Pharmaceutical
Sinochem Pharmaceutical has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Elix Polymers.
Investment portfolio details for Sinochem Pharmaceutical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
ABS resins and filaments are developed for 3D printing applications.
|
Locked | Locked | 1975 | Locked |
Complete acquisition details for Sinochem Pharmaceutical
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Sinochem Pharmaceutical
Detailed financials for Sinochem Pharmaceutical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sinochem Pharmaceutical Comparisons
Peer comparison for Sinochem Pharmaceutical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sinochem Pharmaceutical
Sinochem Pharmaceutical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
Advisory, scientific, and medical communications provided for pharmaceutical industry.
|
|
| Locked | Locked | Locked |
Regulatory support, brand differentiation, and prototyping services are provided.
|
Detailed competitors of Sinochem Pharmaceutical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sinochem Pharmaceutical
Complete news archive for Sinochem Pharmaceutical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sinochem Pharmaceutical
Sinochem Pharmaceutical was founded in 1973.
Sinochem Pharmaceutical is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Annual revenue of Sinochem Pharmaceutical is $26.05M as on Mar 31, 2022.
Sinochem Pharmaceutical was founded in 1973 and is based in Nanjing, China. Operations are conducted in the pharmaceutical sector, where medical instruments, associated products, and medicines are produced. Focus is placed on manufacturing processes for healthcare applications, with distribution handled primarily within domestic markets. The companys online presence is maintained through the domain sinochemjiangsu.com, supporting industry-related activities.
Sinochem Pharmaceutical's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Sinochem Pharmaceutical has made 1 acquisition, including Elix Polymers.